Industry News
GE Healthcare Life Sciences completes acquisition of Xcellerex
GE Healthcare has announced that it has completed the acquisition of Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry. [ + ]
Bioluminescent technology for easy tracking of GM crops
Research published in BioMed Central’s open access journal BMC Biotechnology shows that products from genetically modified crops can be identified at low concentration, using bioluminescent real time reporter (BART) technology and loop mediated isothermal amplification (LAMP). [ + ]
Bioniche burn rate rises on animal health spend
Bioniche (ASX:BNC) revealed its burn rate increased in the March quarter as it stepped up efforts to improve its bottom line through increased animal health sales. [ + ]
Alchemia gaining US share for anticoagulant
US sales of generic fondaparinux, the anticoagulant produced by Alchemia (ASX:ACL), are expected to have grown 120% year-on-year. [ + ]
Bee research breakthrough might lead to artificial vision
An international research breakthrough with bees means machines might soon be able to see almost as well as humans. [ + ]
Scientists develop better technique for creating self-cleaning fabrics
A new coating technique that can make fabrics ‘self-cleaning’ has been developed by Deakin University scientists. The technique creates a fabric coating that repels water, dirt, grease and other materials. [ + ]
Feature: Inside the bacterial machine
Professor Trevor Lithgow is tinkering with the cogs of bacteria to understand how they, and their mitochondrial cousins, tick. [ + ]
IPO-bound Ventus Medical eyes market growth
Ventus Medical plans to use the proceeds of its upcoming ASX IPO to fund efforts to build a market for its sleep disorder breathing products. [ + ]
Phosphagenics lands retail deal with David Jones
Retail chain David Jones has agreed to stock the Elixia range of skincare products from Melbourne-based Phosphagenics (ASX:POH). [ + ]
New vaccine shows promise to protect against common cause of meningitis
Researchers are an important step closer to finding a vaccine that protects against a wide range of strains of meningococcal B - the most common cause of meningococcal disease in Western Australia. [ + ]
Italian researchers make a major discovery into a common form of muscular dystrophy
A new study, published in the international scientific journal Cell, has identified that a novel defect in gene regulation, never before seen in a human disease, is the cause of one of the most common forms of muscular dystrophy: Facioscapulohumeral muscular dystrophy (FSHD). [ + ]
AusBiotech investment mission to sign MOU with HKBIO
An AusBiotech investment mission to Hong Kong later this month will culminate in the signing of a memorandum of understanding (MOU) between AusBiotech and the Hong Kong Biotechnology Organization (HKBIO) to boost biotechnology development. [ + ]
CathRx looks to delist from ASX
Cardiac catheter company CathRx (ASX:CXD) will likely seek shareholder approval to go private after it raises funds to pursue a potential sale of the company. [ + ]
BioDiem, VIVALIS team for viral vector research
BioDiem (ASX:BDM) and France's VIVALIS are exploring the feasibility of using BioDiem's LAIV flu virus to create a viral vector for non-influenza vaccines. [ + ]
Science and biotech survive surplus budget
Despite a budget riddled with cuts, funding for science has increased and the recently-passed R&D Tax Incentive has remained intact. [ + ]
